A Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With CD20-Positive B-Cell Non Hodgkin Lymphoma
Clinical trial NCT01569750 · COMPLETED
Trial details
- NCT number
- NCT01569750
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-14
- Primary completion
- 2014-09-04
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.